<?xml version="1.0" encoding="UTF-8"?>
<ref id="B129-biomedicines-08-00109">
 <label>129.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Delrue</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Verzele</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Madder</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Nauwynck</surname>
    <given-names>H.J.</given-names>
   </name>
  </person-group>
  <article-title>Inactivated virus vaccines: From chemistry to prophylaxis: Merits, risks and challenges. Expert Rev</article-title>
  <source>Vaccines</source>
  <year>2012</year>
  <volume>11</volume>
  <fpage>695</fpage>
  <lpage>719</lpage>
  <pub-id pub-id-type="doi">10.1586/erv.12.38</pub-id>
 </element-citation>
</ref>
